Melinta Therapeutics Shows that Health-Related Quality-of-Life is higher in ABSSSI Patients Deemed Cured vs Improved after End of Treatment
April 09, 2015 12:02 ET
|
Melinta Therapeutics
New Haven, CT, April 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented an evaluation of
Health-Related Quality-of-Life (HRQL) in acute bacterial skin and
skin structure infection...
NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
March 18, 2015 07:06 ET
|
Nemus Bioscience
COSTA MESA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as...
ContraFect Corporation to Present at the 13th Annual BIO Investor Forum
September 30, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Expands Senior Management Team
September 24, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference
September 19, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
September 16, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Separation of Units Sold in IPO
September 09, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
September 03, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
September 02, 2014 17:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option
August 27, 2014 17:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...